Similar articles for PMID: 27461674

Year	Number of Results
1966	1
1976	2
1993	1
1994	2
1995	4
1996	1
1997	1
1998	1
1999	5
2000	5
2001	5
2002	2
2003	4
2004	3
2005	6
2006	7
2007	5
2008	7
2009	2
2010	2
2011	1
2012	3
2013	1
2014	4
2015	4
2016	3
2019	2
2020	1
2022	1
2024	0

1

Iranian women's attitude toward prophylactic mastectomy for breast cancer.

Majidzadeh-A K, Farahmand L, Zare AA, Esmaeili R, Salehi M, Habibi M. Majidzadeh-A K, et al. J Cancer Res Ther. 2016 Apr-Jun;12(2):915-9. doi: 10.4103/0973-1482.171363. J Cancer Res Ther. 2016. PMID: 27461674 Free article.

2

Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.

Hartmann LC, Schaid DJ, Woods JE, Crotty TP, Myers JL, Arnold PG, Petty PM, Sellers TA, Johnson JL, McDonnell SK, Frost MH, Jenkins RB. Hartmann LC, et al. N Engl J Med. 1999 Jan 14;340(2):77-84. doi: 10.1056/NEJM199901143400201. N Engl J Med. 1999. PMID: 9887158 Free article.

3

Comparison of physicians' and cancer prone women's attitudes about breast/ovarian prophylactic surgery. Results from two national surveys.

Eisinger F, Stoppa-Lyonnet D, Lasset C, Vennin P, Chabal F, Noguès C, Moatti JP, Sobol H, Julian-Reynier C. Eisinger F, et al. Fam Cancer. 2001;1(3-4):157-62. doi: 10.1023/a:1021113715998. Fam Cancer. 2001. PMID: 14574172

4

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

Rebbeck TR, Friebel T, Lynch HT, Neuhausen SL, van 't Veer L, Garber JE, Evans GR, Narod SA, Isaacs C, Matloff E, Daly MB, Olopade OI, Weber BL. Rebbeck TR, et al. J Clin Oncol. 2004 Mar 15;22(6):1055-62. doi: 10.1200/JCO.2004.04.188. Epub 2004 Feb 23. J Clin Oncol. 2004. PMID: 14981104

5

Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.

Friebel TM, Domchek SM, Neuhausen SL, Wagner T, Evans DG, Isaacs C, Garber JE, Daly MB, Eeles R, Matloff E, Tomlinson G, Lynch HT, Tung N, Blum JL, Weitzel J, Rubinstein WS, Ganz PA, Couch F, Rebbeck TR. Friebel TM, et al. Clin Breast Cancer. 2007 Dec;7(11):875-82. doi: 10.3816/CBC.2007.n.053. Clin Breast Cancer. 2007. PMID: 18269778

6

A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices.

Geiger AM, Yu O, Herrinton LJ, Barlow WE, Harris EL, Rolnick S, Barton MB, Elmore JG, Fletcher SW. Geiger AM, et al. Arch Intern Med. 2005 Mar 14;165(5):516-20. doi: 10.1001/archinte.165.5.516. Arch Intern Med. 2005. PMID: 15767526

7

Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.

Metcalfe KA, Lubinski J, Ghadirian P, Lynch H, Kim-Sing C, Friedman E, Foulkes WD, Domchek S, Ainsworth P, Isaacs C, Tung N, Gronwald J, Cummings S, Wagner T, Manoukian S, Møller P, Weitzel J, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Metcalfe KA, et al. J Clin Oncol. 2008 Mar 1;26(7):1093-7. doi: 10.1200/JCO.2007.12.6078. Epub 2008 Jan 14. J Clin Oncol. 2008. PMID: 18195327

8

Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.

Meiser B, Butow P, Price M, Bennett B, Berry G, Tucker K; National Consortium for Research into Familial Breast Cancer Psychological Group. Meiser B, et al. J Womens Health (Larchmt). 2003 Oct;12(8):769-78. doi: 10.1089/154099903322447738. J Womens Health (Larchmt). 2003. PMID: 14588127

9

Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers.

Ackermann S, Lux MP, Fasching PA, Strissl P, Renner SP, Poehls U, Bender HG, Beckmann MW. Ackermann S, et al. Eur J Cancer Prev. 2006 Dec;15(6):474-9. doi: 10.1097/01.cej.0000220628.62610.ea. Eur J Cancer Prev. 2006. PMID: 17106324

10

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.

Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD, Klijn J, Friedman E, Kim-Sing C, Ainsworth P, Rosen B, Domchek S, Wagner T, Tung N, Manoukian S, Couch F, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Metcalfe KA, et al. Int J Cancer. 2008 May 1;122(9):2017-22. doi: 10.1002/ijc.23340. Int J Cancer. 2008. PMID: 18196574 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

80 results

Results by year